-
1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1.
Mol Pharmacol. 2005 Dec;68(6):1782-92
PMID: 16155208
-
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways.
Mol Cancer Ther. 2006 May;5(5):1362-70
PMID: 16731770
-
Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects.
J Vasc Res. 2005 Nov-Dec;42(6):509-16
PMID: 16155367
-
A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.
Mol Cancer Ther. 2004 Mar;3(3):247-60
PMID: 15026545
-
Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand.
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2340-5
PMID: 15701701
-
Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways.
Cancer Res. 2007 Jan 15;67(2):674-83
PMID: 17234778
-
A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity.
Cancer Res. 1999 Jan 15;59(2):336-41
PMID: 9927043
-
1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways.
Mol Pharmacol. 2007 Feb;71(2):558-69
PMID: 17093136
-
A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
Mol Endocrinol. 2002 Nov;16(11):2628-44
PMID: 12403851
-
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways.
Mol Cancer Ther. 2006 Sep;5(9):2324-36
PMID: 16985067
-
Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
J Biol Chem. 2004 Feb 20;279(8):6883-92
PMID: 14662774
-
1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells.
Cancer Res. 2004 Sep 1;64(17):5994-6001
PMID: 15342379
-
A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia.
Cancer Res. 2005 Apr 1;65(7):2890-8
PMID: 15805291
-
3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5.
Carcinogenesis. 2006 Apr;27(4):717-28
PMID: 16332727
-
2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells.
Carcinogenesis. 2007 Nov;28(11):2337-46
PMID: 17724373
-
Peroxisome proliferator-activated receptors: insight into multiple cellular functions.
Mutat Res. 2000 Mar 17;448(2):121-38
PMID: 10725467
-
Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis.
J Mol Endocrinol. 2001 Aug;27(1):1-9
PMID: 11463572
-
Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins.
Endocrinology. 2004 Dec;145(12):5774-85
PMID: 15345676
-
Benzoyl 2-methyl indoles as selective PPARgamma modulators.
Bioorg Med Chem Lett. 2005 Jan 17;15(2):357-62
PMID: 15603954
-
Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.
Mol Cancer Ther. 2007 May;6(5):1588-98
PMID: 17513608
-
Inhibition of breast cancer cell growth and induction of cell death by 1,1-bis(3'-indolyl)methane (DIM) and 5,5'-dibromoDIM.
Cancer Lett. 2006 May 18;236(2):198-212
PMID: 16051428
-
1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6743-52
PMID: 18006776
-
15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Mol Pharmacol. 2005 Nov;68(5):1203-13
PMID: 16077033
-
Selective PPARgamma modulators with improved pharmacological profiles.
Bioorg Med Chem Lett. 2005 May 16;15(10):2437-40
PMID: 15863293
-
(2R)-2-ethylchromane-2-carboxylic acids: discovery of novel PPARalpha/gamma dual agonists as antihyperglycemic and hypolipidemic agents.
J Med Chem. 2004 Jun 3;47(12):3255-63
PMID: 15163205
-
Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.
J Biol Chem. 2003 Feb 21;278(8):5845-53
PMID: 12475986
-
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Breast Cancer Res Treat. 2008 May;109(2):273-83
PMID: 17624585
-
Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.
Mol Endocrinol. 2003 Apr;17(4):662-76
PMID: 12554792
-
Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.
Cancer Res. 2006 Jan 1;66(1):412-8
PMID: 16397256